Canada confirms 1st case of rare blood clot after AstraZeneca COVID-19 vaccine
The first case of a rare but potentially fatal blood clot has been recorded in a woman in Canada after receiving the AstraZeneca-Oxford COVID-19 vaccine.
Full Article
Canada confirms 1st case of rare blood clot after AstraZeneca COVID-19 vaccine
CBC.ca
0 shares
2 views
You might like
Related news coverage
Rare COVID-19 vaccine blood clots explained
CBC.ca
With the news that a woman in Quebec died of a rare blood clot after receiving the AstraZeneca-Oxford COVID-19 vaccine, some people..
-
Quebec confirms 1st death related to rare AstraZeneca-linked blood clots, emphasizes benefits outweigh risks
CBC.ca
-
Ontario reports third blood clot associated with AstraZeneca’s COVID-19 vaccine
CP24
-
Ontario man speaks out after father has severe stroke from rare blood clot following AstraZeneca vaccine
CBC.ca
-
The Latest: Pakistan reports highest daily death toll
SeattlePI.com
Advertisement
More coverage
Oxford/AstraZeneca Covid vaccine blood clot cases rise above 150
Wales Online
Overall, rare blood clots occurred in 93 women and 75 men aged between 18 and 93
-
Canada reaches deal with Pfizer for vaccines in future years
SeattlePI.com
-
Ontario reports first blood clot case associated with AstraZeneca shot; officials say condition remains ‘extremely rare’
CP24
-
EU agency says people should get 2nd dose of AstraZeneca too
SeattlePI.com
-
EU agency to issue more guidance on AstraZeneca's COVID shot
SeattlePI.com